Cargando…

Everolimus in the Treatment of Metastatic Breast Cancer

The discovery of the mammalian target of rapamycin (mTOR) molecular pathway has brought insight into its vital role in breast cancer pathogenesis. Several clinical trials have shown that the mTOR inhibitor everolimus could improve patient outcomes in several subtypes of breast cancer, including horm...

Descripción completa

Detalles Bibliográficos
Autores principales: Royce, Melanie E, Osman, Diaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571987/
https://www.ncbi.nlm.nih.gov/pubmed/26417203
http://dx.doi.org/10.4137/BCBCR.S29268